Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria Gonzalez-Cao"'
Autor:
Carmen Sandoval, Edel del Barco, M. Angeles Sala, Virginia Calvo, Pilar Diz, Manuel Domine, Xabier Mielgo Rubio, Antonio Calles, I. Sullivan, José Ramón Jarabo, C. Pangua, Gema Garcia Ledo, Ernest Nadal, Javier Baena, Rosa Alvarez, Ana Lopez-Martin, M. Antoñanzas, Elia Sais Girona, Rafael López Castro, Mariano Provencio, Jose Maria Mazarico Gallego, Maria Gonzalez-Cao
Publikováno v:
Clinical Cancer Research. 27:S12-04
Background: Previous reports indicate that lung cancer patients are at an increased risk of severe COVID-19 disease and higher mortality rate compared to general population. However, prognostic factors are not yet clearly identified. The LunG canceR
Autor:
Niki Karachaliou, Cristina Teixidó, Miguel Angel Molina-Vila, Ariadna Balada, Mónica Garzón, Clara Mayo de las Casas, Maria Gonzalez-Cao, Santiago Viteri Ramirez, Nuria Jordana Ariza, Rafael Rosell, Daniela Morales-Espinosa
Publikováno v:
Translational Lung Cancer Research. 5:532-537
Genomic analysis of circulating tumor DNA (ctDNA) released from cancer cells into the bloodstream has been proposed as a useful method to capture dynamic changes during the course of the disease. In particular, the ability to monitor epidermal growth
Autor:
Giuseppe Altavilla, Alessandro D'Aveni, Niki Karachaliou, Maria Grazia Daffinà, Alessia Liguori, Maria Gonzalez-Cao, Rafael Rosell, Mariacarmela Santarpia, Chiara Lazzari
Publikováno v:
Journal of Thoracic Disease
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Molecularly targeted therapies and immune checkpoint inhibitors have markedly improved the therapeutic management of advanced lung cancer. However, it still remains the leading cause of cancer-related mortality worldwide, with disease stage at diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8192797fc81b0f79efeb2001eec06dc
https://europepmc.org/articles/PMC5945693/
https://europepmc.org/articles/PMC5945693/
Autor:
Ivan Marquez-Rodas, Jose Luis Manzano, Salvador Martín-Algarra, Maria Gonzalez-Cao, Ainara Soria, Enrique Espinosa, Alfonso Berrocal
Publikováno v:
Annals of translational medicine. 5(19)
Immunotherapy has become a key element in the treatment of several tumors, such as lung carcinoma and melanoma. Immunotherapy, unlike classical chemotherapy and targeted drugs, may yield long-term survival, even in patients who stop treatment due to
Autor:
Mariacarmela Santarpia, Maria Gonzalez Cao, Aaron E. Sosa, Feliciano Barrón, Niki Karachaliou, Rafael Rosell
Publikováno v:
Expert opinion on pharmacotherapy. 18(3)
Lung cancer is the leading cause of cancer death in both genders. In the early stages the disease is asymptomatic and most patients appear with metastasis at the time of the diagnosis. The discovery of key oncogenic events mainly in lung adenocarcino
Autor:
Pablo Cerezuela, Laura Alós, Susana Puig, Santiago Viteri, Salvador Martín-Algarra, Maria Gonzalez-Cao, Ana Arance, Mar Carrasco-Calvo, Alfonso Berrocal, Ainara Soria
Publikováno v:
Annals of Translational Medicine. 5:392-392
Melanoma is the most lethal skin tumor and its incidence has increased dramatically in the western world during the last decades. The adjusted incidence rate of melanoma in Spain is 5.2 per 100,000 inhabitants/year, with higher prevalence among women
Autor:
Jordi Bertran-Alamillo, Clara Mayo de las Casas, Maria Gonzalez Cao, Niki Karachaliou, Daniela Morales-Espinosa, Miguel Angel Molina-Vila, Elena Ovalle, Mónica Garzón, Marc Simo-Perdigo, Jordi Codony, Xavier Gonzalez, Ana Pérez-Rosado, Rafael Rosell, Santiago Viteri Ramirez, Alejandro Martinez-Bueno, Núria Jordana-Ariza
Publikováno v:
Journal of Clinical Oncology. 33:e19085-e19085
e19085 Background: Repeat biopsies of cancer p are useful for monitoring molecular evolution of the disease and the possible appearance or disappearance of key somatic mutations, particularly those...